Gene · 51684
Papers2,311
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,311
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| European Association of Neuro-Oncology guideline on molecular testing of meningiomas for targeted therapy selection. | Neuro Oncol | 2025 | 39577862 | PubTator, text mining | PubMed |
| Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome. | J Dermatol | 2025 | 39158191 | PubTator, text mining | PubMed |
| Study of the Immune Infiltration and Sonic Hedgehog Expression Mechanism in Synovial Tissue of Rheumatoid Arthritis-Related Interstitial Lung Disease under Machine Learning CIBERSORT Algorithm. | Mol Biotechnol | 2025 | 39110383 | PubTator, text mining | PubMed |
| Clinical vs. molecular diagnosis of Gorlin syndrome: relevance of diagnostic criteria depends on the age of the patients. | Clin Exp Dermatol | 2025 | 38768301 | PubTator, text mining | PubMed |
| Genomic landscape of medulloblastoma subtypes in an Asian cohort. | Transl Cancer Res | 2024 | 39816537 | PubTator, text mining | PubMed |
| Genetic variants associated with sepsis-associated acute kidney injury. | PLoS One | 2024 | 39636799 | PubTator, text mining | PubMed |
| Mining differentially expressed genes during paratomy in the transcriptome of the flatworm Stenostomum leucops. | Sci Rep | 2024 | 39587261 | PubTator, text mining | PubMed |
| Retraction: LIFR-AS1 modulates Sufu to inhibit cell proliferation and migration by miR-197-3p in breast cancer. | Biosci Rep | 2024 | 39544032 | PubTator, text mining | PubMed |
| Whole genome sequencing elucidates etiological differences in MCPyV-negative Merkel cell carcinoma. | Pathol Res Pract | 2024 | 39427588 | PubTator, text mining | PubMed |
| Exploration of the causative gene in a case of multiple nevoid basal cell carcinoma: A case report. | Rare Tumors | 2024 | 39399445 | PubTator, text mining | PubMed |
| Cysteine-Persulfide Sulfane Sulfur-Ligated Zn Complex of Sulfur-Carrying SufU in the SufCDSUB System for Fe-S Cluster Biosynthesis. | Inorg Chem | 2024 | 39384553 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs: Emerging insights into therapeutic potential and mechanisms in bone healing. | J Tissue Eng | 2024 | 39371940 | PubTator, text mining | PubMed |
| Successful Radiotherapy for Metastatic Basal Cell Carcinoma to the Parotid Gland in a Patient With Gorlin-Goltz Syndrome. | Cureus | 2024 | 39295706 | PubTator, text mining | PubMed |
| Inherited Basaloid Neoplasms Associated With SUFU Pathogenic Variants. | JAMA Dermatol | 2024 | 39292485 | PubTator, text mining | PubMed |
| Clinicopathological and molecular spectrum of patients with germline SUFU mutations: A case series. | J Cutan Pathol | 2024 | 39276021 | PubTator, text mining | PubMed |
| Pleiotropy in FOXC1-attributable phenotypes involves altered ciliation and cilia-dependent signaling. | Sci Rep | 2024 | 39217245 | PubTator, text mining | PubMed |
| Frequency of pathogenic germline variants in pediatric medulloblastoma survivors. | Front Oncol | 2024 | 39184053 | PubTator, text mining | PubMed |
| Developmental, Cognitive, Ocular Motor, and Neuroimaging Findings Related to SUFU Haploinsufficiency: Unraveling Subtle and Highly Variable Phenotypes. | Pediatr Neurol | 2024 | 39181021 | PubTator, text mining | PubMed |
| Characterization, mechanisms, structure-activity relationships, and antihypertensive effects of ACE inhibitory peptides: rapid screening from sufu hydrolysate. | Food Funct | 2024 | 39158526 | PubTator, text mining | PubMed |
| The structure of the SufS-SufE complex reveals interactions driving protected persulfide transfer in iron-sulfur cluster biogenesis. | J Biol Chem | 2024 | 39122000 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51684/papers?page=5